Consultation process
At Elios Clinics, we understand that accessing medical cannabis can be a complex and daunting process. That’s why our team is dedicated to making your journey as seamless and transparent as possible. We are committed to keeping you informed at every step, from submitting your eligibility application to receiving your prescription(s). To get started, you can create an account on our website and complete our eligibility questionnaire. We will then request relevant medical records from you to confirm whether medical cannabis is a suitable treatment option for you. If necessary, we can also obtain the records on your behalf. Our clinicians will review your application and, if appropriate, progress you to the next stage. We will ask you to confirm that you understand our terms of treatment, and we will verify your identity. Once you’ve completed the initial steps, you’ll receive an invitation to book a virtual consultation with our clinicians. Our healthcare professionals will review your medical history during the consultation and discuss your symptoms and treatment goals.
This information will then shared with our Multi-Disciplinary Team (MDT), composed of doctors and pharmacists who will ensure that any medication prescribed is appropriate and safe for you. If the MDT approves your case, your prescription will be sent to you via the pharmacy. Our partner pharmacy will contact you to arrange payment and dispensation. We will also keep you up-to date and provide reminders for any required follow-up consultations. If you need to request more medication, you can easily log in and make a prescription request. Our team will review your request and provide you with the necessary information and support. At Elios Clinics, we are committed to providing our patients with the highest care and support throughout their medical cannabis journey. Our team of experienced healthcare professionals is dedicated to ensuring you access safe and effective treatment options that meet your unique needs and circumstances.